SH PHARMA: No Share Capital Movement in June 2026; 3.71 Billion Total Authorised Shares and Public Float Fully Compliant

Bulletin Express07-02

Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) filed its Monthly Return for the period ended 30 June 2026, confirming stable capital structure and full compliance with public-float requirements on the Hong Kong Stock Exchange (HKEX).

Authorised / Registered Capital • H-shares: 919.07 million authorised shares at RMB 1 par value, unchanged from the previous month. • A-shares: 2.79 billion authorised shares at RMB 1 par value, also unchanged. • Combined authorised share capital stood at 3.71 billion shares.

Issued Shares • H-shares in issue totalled 919.07 million; no treasury shares were held or cancelled during the month. • A-shares in issue totalled 2.79 billion; likewise, no treasury shares were recorded. • No share options, warrants, convertibles or other instruments were outstanding or exercised.

Public Float Status SH PHARMA confirmed that its H-share public float met the HKEX minimum threshold of 5% for PRC issuers with dual listings as of 30 June 2026.

Regulatory Compliance The company attested that all applicable listing-rule and legal requirements were observed, with no changes in share classes, rights, or documentation.

Key Takeaway June 2026 saw no movements in SH PHARMA’s share capital. The issuer maintains a 3.71 billion-share authorised base and remains fully compliant with HKEX public-float rules.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1176538209?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-02 17:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176538209","market":"us","top_or_hot":-1,"title":"SH PHARMA: No Share Capital Movement in June 2026; 3.71 Billion Total Authorised Shares and Public Float Fully Compliant","media":"Bulletin Express","content":"<p>Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) filed its Monthly Return for the period ended 30 June 2026, confirming stable capital structure and full compliance with public-float requirements on the Hong Kong Stock Exchange (HKEX).</p>\n<p>Authorised / Registered Capital  \n• H-shares: 919.07 million authorised shares at RMB 1 par value, unchanged from the previous month.  \n• A-shares: 2.79 billion authorised shares at RMB 1 par value, also unchanged.  \n• Combined authorised share capital stood at 3.71 billion shares.</p>\n<p>Issued Shares  \n• H-shares in issue totalled 919.07 million; no treasury shares were held or cancelled during the month.  \n• A-shares in issue totalled 2.79 billion; likewise, no treasury shares were recorded.  \n• No share options, warrants, convertibles or other instruments were outstanding or exercised.</p>\n<p>Public Float Status  \nSH PHARMA confirmed that its H-share public float met the HKEX minimum threshold of 5% for PRC issuers with dual listings as of 30 June 2026.</p>\n<p>Regulatory Compliance  \nThe company attested that all applicable listing-rule and legal requirements were observed, with no changes in share classes, rights, or documentation.</p>\n<p>Key Takeaway  \nJune 2026 saw no movements in SH PHARMA’s share capital. The issuer maintains a 3.71 billion-share authorised base and remains fully compliant with HKEX public-float rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SH PHARMA: No Share Capital Movement in June 2026; 3.71 Billion Total Authorised Shares and Public Float Fully Compliant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSH PHARMA: No Share Capital Movement in June 2026; 3.71 Billion Total Authorised Shares and Public Float Fully Compliant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-02 17:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) filed its Monthly Return for the period ended 30 June 2026, confirming stable capital structure and full compliance with public-float requirements on the Hong Kong Stock Exchange (HKEX).</p>\n<p>Authorised / Registered Capital  \n• H-shares: 919.07 million authorised shares at RMB 1 par value, unchanged from the previous month.  \n• A-shares: 2.79 billion authorised shares at RMB 1 par value, also unchanged.  \n• Combined authorised share capital stood at 3.71 billion shares.</p>\n<p>Issued Shares  \n• H-shares in issue totalled 919.07 million; no treasury shares were held or cancelled during the month.  \n• A-shares in issue totalled 2.79 billion; likewise, no treasury shares were recorded.  \n• No share options, warrants, convertibles or other instruments were outstanding or exercised.</p>\n<p>Public Float Status  \nSH PHARMA confirmed that its H-share public float met the HKEX minimum threshold of 5% for PRC issuers with dual listings as of 30 June 2026.</p>\n<p>Regulatory Compliance  \nThe company attested that all applicable listing-rule and legal requirements were observed, with no changes in share classes, rights, or documentation.</p>\n<p>Key Takeaway  \nJune 2026 saw no movements in SH PHARMA’s share capital. The issuer maintains a 3.71 billion-share authorised base and remains fully compliant with HKEX public-float rules.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02607","symbol_name":"上海医药","start_time":0,"source_url":"","article_id":"1176538209","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176538209","pubTimestamp":1782984710,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) filed its Monthly Return for the period ended 30 June 2026, confirming stable capital structure and full compliance with public-float...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02607":"上海医药"},"translate_title":"上海医药：2026年6月无股本变动；37.1亿股法定股份总数和公众持股量完全合规","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02607":1},"content_text":"Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) filed its Monthly Return for the period ended 30 June 2026, confirming stable capital structure and full compliance with public-float requirements on the Hong Kong Stock Exchange (HKEX).\nAuthorised / Registered Capital  \n• H-shares: 919.07 million authorised shares at RMB 1 par value, unchanged from the previous month.  \n• A-shares: 2.79 billion authorised shares at RMB 1 par value, also unchanged.  \n• Combined authorised share capital stood at 3.71 billion shares.\nIssued Shares  \n• H-shares in issue totalled 919.07 million; no treasury shares were held or cancelled during the month.  \n• A-shares in issue totalled 2.79 billion; likewise, no treasury shares were recorded.  \n• No share options, warrants, convertibles or other instruments were outstanding or exercised.\nPublic Float Status  \nSH PHARMA confirmed that its H-share public float met the HKEX minimum threshold of 5% for PRC issuers with dual listings as of 30 June 2026.\nRegulatory Compliance  \nThe company attested that all applicable listing-rule and legal requirements were observed, with no changes in share classes, rights, or documentation.\nKey Takeaway  \nJune 2026 saw no movements in SH PHARMA’s share capital. The issuer maintains a 3.71 billion-share authorised base and remains fully compliant with HKEX public-float rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1176538209","isCrawlerRequest":true}